13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
We are all familiar with the federal WARN Act, which requires that employers give defined notices to...
Read More >
In OTO, L.L.C. v. Kho, the California Supreme Court refused to enforce an employee’s arbitration ag...
Read More >
A recent report showing slowing US manufacturing activity and a sliding 10-year Treasury note yield ...
Read More >
Overlooking the ultimate beneficiary of a third party can be materially and publicly damaging for an...
Read More >
It seems there’s never a dull moment in the U.S.-China bilateral relationship. Public markets relax...
Read More >
Regulators, judges and academics have all been vexed over the issue of whether obesity, not caused b...
Read More >